Literature DB >> 29031143

C5a/C5aR pathway accelerates renal ischemia-reperfusion injury by downregulating PGRN expression.

Kun Zhang1, Gui-Qing Li2, Qian-Hui He1, You Li1, Ming Tang1, Quan-You Zheng1, Gui-Lian Xu2, Ke-Qin Zhang3.   

Abstract

Recent reports indicate that the complement C5a/C5aR pathway and progranulin (PGRN) deficiency both contribute to ischemia-reperfusion (IR)-induced acute kidney injury. However, the underlying relationship between the C5a/C5aR signaling pathway and PGRN expression during acute kidney injury is poorly understood. In this study, we showed that C5aR expression was significantly upregulated after renal IR, and that C5aR deficiency led to a marked increase in PGRN expression and a significant reduction in tubular damage and production of inflammatory cytokines. In accordance with these results, recombinant C5a caused downregulation of PGRN protein and mRNA levels in renal tubular epithelial cells (HK-2 cells), which could be negated by disruption of C5a/C5aR signaling by the C5aR antagonist, as confirmed by immunofluorescence, western blotting, and quantitative real-time PCR. Moreover, C5aR deficiency resulted in attenuated NF-κB expression 24h after IR, and recombinant C5a potentiated TNFα-induced NF-κB activation in HK-2 cells. Inhibition of NF-κB activation reversed C5a-induced downregulation of PGRN expression. Our results show for the first time that the complement C5a/C5aR pathway aggravates IR-induced acute kidney injury by suppressing PGRN expression and confirm that suppression of PGRN expression is associated with increased NF-κB activation induced by C5a.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  C5a/C5aR pathway; Ischemic-reperfusion injury; NF-κB; Progranulin

Mesh:

Substances:

Year:  2017        PMID: 29031143     DOI: 10.1016/j.intimp.2017.10.006

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  9 in total

1.  Mesenchymal stem cells alleviate acute kidney injury by down-regulating C5a/C5aR pathway activation.

Authors:  Ming Tang; Kun Zhang; You Li; Qian-Hui He; Gui-Qing Li; Quan-You Zheng; Ke-Qin Zhang
Journal:  Int Urol Nephrol       Date:  2018-03-28       Impact factor: 2.370

2.  The potential role of complement alternative pathway activation in hypertensive renal damage.

Authors:  Chongjian Wang; Zhiyu Wang; Wen Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-27

Review 3.  Perspectives on the Optimal Genetically Engineered Pig in 2018 for Initial Clinical Trials of Kidney or Heart Xenotransplantation.

Authors:  David K C Cooper; Mohamed Ezzelarab; Hayato Iwase; Hidetaka Hara
Journal:  Transplantation       Date:  2018-12       Impact factor: 4.939

4.  Complement Activation During Ischemia/Reperfusion Injury Induces Pericyte-to-Myofibroblast Transdifferentiation Regulating Peritubular Capillary Lumen Reduction Through pERK Signaling.

Authors:  Giuseppe Castellano; Rossana Franzin; Alessandra Stasi; Chiara Divella; Fabio Sallustio; Paola Pontrelli; Giuseppe Lucarelli; Michele Battaglia; Francesco Staffieri; Antonio Crovace; Giovanni Stallone; Marc Seelen; Mohamed R Daha; Giuseppe Grandaliano; Loreto Gesualdo
Journal:  Front Immunol       Date:  2018-05-23       Impact factor: 7.561

Review 5.  Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage.

Authors:  Rossana Franzin; Alessandra Stasi; Marco Fiorentino; Giovanni Stallone; Vincenzo Cantaluppi; Loreto Gesualdo; Giuseppe Castellano
Journal:  Front Immunol       Date:  2020-05-07       Impact factor: 7.561

6.  Complement component C5a induces aberrant epigenetic modifications in renal tubular epithelial cells accelerating senescence by Wnt4/βcatenin signaling after ischemia/reperfusion injury.

Authors:  Giuseppe Castellano; Rossana Franzin; Fabio Sallustio; Alessandra Stasi; Barbara Banelli; Massimo Romani; Giuseppe De Palma; Giuseppe Lucarelli; Chiara Divella; Michele Battaglia; Antonio Crovace; Francesco Staffieri; Giuseppe Grandaliano; Giovanni Stallone; Pasquale Ditonno; Paolo Cravedi; Vincenzo Cantaluppi; Loreto Gesualdo
Journal:  Aging (Albany NY)       Date:  2019-07-08       Impact factor: 5.682

Review 7.  Progranulin Regulates Inflammation and Tumor.

Authors:  Chunxiao Liu; Jiayi Li; Wenjing Shi; Liujia Zhang; Shuang Liu; Yingcong Lian; Shujuan Liang; Hongyan Wang
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2020

8.  Progranulin and Its Receptor Predict Kidney Function Decline in Patients With Type 2 Diabetes.

Authors:  Maki Murakoshi; Tomohito Gohda; Hiroko Sakuma; Terumi Shibata; Eri Adachi; Chiaki Kishida; Saki Ichikawa; Takeo Koshida; Nozomu Kamei; Yusuke Suzuki
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-01       Impact factor: 6.055

9.  LIGHT deficiency attenuates acute kidney disease development in an in vivo experimental renal ischemia and reperfusion injury model.

Authors:  Quan-You Zheng; You Li; Shen-Ju Liang; Xi-Ming Chen; Ming Tang; Zheng-Sheng Rao; Gui-Qing Li; Jian-Li Feng; Yu Zhong; Jian Chen; Gui-Lian Xu; Ke-Qin Zhang
Journal:  Cell Death Discov       Date:  2022-09-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.